A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression.

PubWeight™: 1.92‹?› | Rank: Top 3%

🔗 View Article (PMC 112166)

Published in J Virol on July 01, 2000

Authors

H O Li1, Y F Zhu, M Asakawa, H Kuma, T Hirata, Y Ueda, Y S Lee, M Fukumura, A Iida, A Kato, Y Nagai, M Hasegawa

Author Affiliations

1: DNAVEC Research Inc., Tsukuba-shi, Ibaraki 305-0856, Japan.

Articles citing this

Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci (2009) 5.58

Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. J Exp Med (2004) 2.99

Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci U S A (2011) 2.51

Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming. J Biol Chem (2010) 1.59

Gag-specific cytotoxic T-lymphocyte-based control of primary simian immunodeficiency virus replication in a vaccine trial. J Virol (2008) 1.38

Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques. J Virol (2006) 1.33

Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus. Nat Protoc (2012) 1.31

Technological overview of iPS induction from human adult somatic cells. Curr Gene Ther (2013) 1.13

A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading. J Virol (2003) 1.10

Type I interferon-sensitive recombinant newcastle disease virus for oncolytic virotherapy. J Virol (2010) 1.07

Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine. J Virol (2007) 1.07

Impact of cytotoxic-T-lymphocyte memory induction without virus-specific CD4+ T-Cell help on control of a simian immunodeficiency virus challenge in rhesus macaques. J Virol (2009) 1.06

Nontransmissible virus-like particle formation by F-deficient sendai virus is temperature sensitive and reduced by mutations in M and HN proteins. J Virol (2003) 1.06

Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes. Stem Cells Transl Med (2012) 1.02

Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors. Stem Cells Transl Med (2013) 1.00

Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model. J Virol (2003) 0.99

Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions. Stem Cells Int (2012) 0.98

RNA replicons - a new approach for influenza virus immunoprophylaxis. Viruses (2010) 0.97

Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques. J Virol (2007) 0.97

Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine. Curr Gene Ther (2012) 0.97

DVC1-0101 to treat peripheral arterial disease: a Phase I/IIa open-label dose-escalation clinical trial. Mol Ther (2013) 0.91

Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus. J Virol (2003) 0.90

Vectorology and factor delivery in induced pluripotent stem cell reprogramming. Stem Cells Dev (2014) 0.88

An efficient and versatile mammalian viral vector system for major histocompatibility complex class I/peptide complexes. J Virol (2002) 0.87

RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications. J Cardiovasc Transl Res (2013) 0.84

A novel protective MHC-I haplotype not associated with dominant Gag-specific CD8+ T-cell responses in SIVmac239 infection of Burmese rhesus macaques. PLoS One (2013) 0.84

Cytokine-based log-scale expansion of functional murine dendritic cells. PLoS One (2009) 0.83

Urokinase-targeted fusion by oncolytic Sendai virus eradicates orthotopic glioblastomas by pronounced synergy with interferon-β gene. Mol Ther (2010) 0.82

Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy. World J Gastroenterol (2014) 0.81

RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer. Neoplasia (2010) 0.81

Viral and Synthetic RNA Vector Technologies and Applications. Mol Ther (2016) 0.80

Elicitation of both anti HIV-1 Env humoral and cellular immunities by replicating vaccinia prime Sendai virus boost regimen and boosting by CD40Lm. PLoS One (2012) 0.79

Induced pluripotent stem cells as a source of hepatocytes. Curr Pathobiol Rep (2014) 0.79

Studies on the paramyxovirus accessory genes by reverse genetics in the Sendai virus-mouse system. Proc Jpn Acad Ser B Phys Biol Sci (2008) 0.78

Derivation of transgene-free human induced pluripotent stem cells from human peripheral T cells in defined culture conditions. PLoS One (2014) 0.78

Cytokine-based high log-scale expansion of functional human dendritic cells from cord-blood CD34-positive cells. Sci Rep (2011) 0.78

Nuclear reprogramming with a non-integrating human RNA virus. Stem Cell Res Ther (2015) 0.76

Hyaluronic acid pretreatment for Sendai virus-mediated cochlear gene transfer. Gene Ther (2015) 0.76

Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice. Mol Ther (2017) 0.75

Skin Biopsy and Patient-Specific Stem Cell Lines. Methods Mol Biol (2016) 0.75

Generation of Induced Pluripotent Stem Cells from Human Peripheral T Cells Using Sendai Virus in Feeder-free Conditions. J Vis Exp (2015) 0.75

In vitro transdifferentiation of human peripheral blood mononuclear cells to photoreceptor-like cells. Biol Open (2016) 0.75

Derivation and long-term culture of transgene-free human induced pluripotent stem cells on synthetic substrates. Stem Cells Transl Med (2014) 0.75

Cellular Reprogramming Using Protein and Cell-Penetrating Peptides. Int J Mol Sci (2017) 0.75

Human parainfluenza virus type 2 vector induces dendritic cell maturation without viral RNA replication/transcription. Hum Gene Ther (2013) 0.75

Simple Derivation of Spinal Motor Neurons from ESCs/iPSCs Using Sendai Virus Vectors. Mol Ther Methods Clin Dev (2017) 0.75

Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editing. Mol Ther Methods Clin Dev (2016) 0.75

A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects. Front Aging Neurosci (2016) 0.75

Articles cited by this

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 32.58

Identification of a neural stem cell in the adult mammalian central nervous system. Cell (1999) 6.53

Rat hippocampal neurons in dispersed cell culture. Brain Res (1977) 5.29

Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene. Proc Natl Acad Sci U S A (1991) 4.35

Rescue of a foreign gene by Sendai virus. Proc Natl Acad Sci U S A (1991) 3.85

Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc Natl Acad Sci U S A (1996) 3.54

Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell (1997) 3.46

Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells (1996) 3.41

Attenuated vesicular stomatitis viruses as vaccine vectors. J Virol (1999) 3.04

The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO J (1991) 2.83

A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J (1998) 2.48

Negative-strand RNA viruses: genetic engineering and applications. Proc Natl Acad Sci U S A (1996) 2.47

Nonsegmented negative-strand RNA viruses: genetics and manipulation of viral genomes. Annu Rev Genet (1998) 2.42

A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells. Cell (1997) 2.35

Alphavirus-based expression vectors: strategies and applications. Proc Natl Acad Sci U S A (1996) 2.18

Rescue of synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene. Virology (1995) 2.11

Recovery of negative-strand RNA viruses from plasmid DNAs: a positive approach revitalizes a negative field. Virology (1998) 1.75

Highly stable expression of a foreign gene from rabies virus vectors. Proc Natl Acad Sci U S A (1996) 1.72

Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene. J Virol (1996) 1.62

Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light. J Virol (1996) 1.58

HVJ (Sendai virus)-induced envelope fusion and cell fusion are blocked by monoclonal anti-HN protein antibody that does not inhibit hemagglutination activity of HVJ. Exp Cell Res (1982) 1.46

A recombinant measles virus expressing biologically active human interleukin-12. J Gen Virol (1999) 1.38

Paramyxovirus reverse genetics is coming of age. Microbiol Immunol (1999) 1.37

Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3' proximal first locus. J Gen Virol (1997) 1.35

Efficient gene activation system on mammalian cell chromosomes using recombinant adenovirus producing Cre recombinase. Gene (1996) 1.30

Alphavirus expression systems. Curr Opin Biotechnol (1994) 1.07

A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines. J Virol (1998) 1.02

Long-term replication of Sendai virus defective interfering particle nucleocapsids in stable helper cell lines. J Virol (1994) 1.02

Sendai virus-based expression of HIV-1 gp120: reinforcement by the V(-) version. Genes Cells (1997) 1.01

Synaptic transmission between pairs of retinal amacrine cells in culture. J Neurosci (1993) 0.95

RNA virus vectors: where are we and where do we need to go? Proc Natl Acad Sci U S A (1998) 0.90

The roles of individual cysteine residues of Sendai virus fusion protein in intracellular transport. J Biochem (1998) 0.87

Purification and characterization of a 15 kDa protein (p15) produced by Helicosporium that exhibits distinct effects on neurite outgrowth from cortical neurons and PC12 cells. Biochem Biophys Res Commun (1996) 0.82

Large quantity production with extreme convenience of human SDF-1alpha and SDF-1beta by a Sendai virus vector. FEBS Lett (1998) 0.81

Articles by these authors

Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol (1985) 47.78

The complete nucleotide sequence of the tobacco chloroplast genome: its gene organization and expression. EMBO J (1986) 19.59

Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet (2001) 18.55

Evaluation of the maximum likelihood estimate of the evolutionary tree topologies from DNA sequence data, and the branching order in hominoidea. J Mol Evol (1989) 16.24

Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature (1997) 13.77

CONSEL: for assessing the confidence of phylogenetic tree selection. Bioinformatics (2001) 11.90

MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med (1999) 9.23

Evolutionary relationship of archaebacteria, eubacteria, and eukaryotes inferred from phylogenetic trees of duplicated genes. Proc Natl Acad Sci U S A (1989) 8.45

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A (1998) 8.41

Complete genome sequence of an aerobic hyper-thermophilic crenarchaeon, Aeropyrum pernix K1. DNA Res (1999) 7.39

Complete sequence and gene organization of the genome of a hyper-thermophilic archaebacterium, Pyrococcus horikoshii OT3. DNA Res (1998) 6.79

Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet (1998) 6.09

Isolation and characterization of acid phosphatase mutants in Saccharomyces cerevisiae. J Bacteriol (1973) 5.24

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology (1976) 4.85

Studies on protein folding, unfolding and fluctuations by computer simulation. I. The effect of specific amino acid sequence represented by specific inter-unit interactions. Int J Pept Protein Res (1975) 4.49

Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature (1996) 4.12

Gene transfer to the nucleus and the evolution of chloroplasts. Nature (1998) 3.79

Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med (2000) 3.74

Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55

Model of amino acid substitution in proteins encoded by mitochondrial DNA. J Mol Evol (1996) 3.53

Tadpole collagenase. Preparation and purification. Biochemistry (1966) 3.50

Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells (1996) 3.41

IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology (2010) 3.34

In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J Immunol (1981) 3.34

Renal transplantation in baboons under FK 506. Surgery (1989) 3.17

A glycolipid on the surface of mouse natural killer cells. Eur J Immunol (1980) 3.13

Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc (1987) 3.11

Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol (2000) 3.10

p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. EMBO J (1993) 3.06

Ribosomal RNA trees misleading? Nature (1993) 3.04

Models of amino acid substitution and applications to mitochondrial protein evolution. Mol Biol Evol (1998) 3.03

Complete genome sequence of an aerobic thermoacidophilic crenarchaeon, Sulfolobus tokodaii strain7. DNA Res (2001) 2.99

Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron (1997) 2.93

Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology (2008) 2.85

Isolation and characterization of recessive, constitutive mutations for repressible acid phosphatase synthesis in Saccharomyces cerevisiae. J Bacteriol (1975) 2.71

The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J (1997) 2.71

Specific degradation of the collagen molecule by tadpole collagenolytic enzyme. Proc Natl Acad Sci U S A (1965) 2.61

Molecular clock of silent substitution: at least six-fold preponderance of silent changes in mitochondrial genes over those in nuclear genes. J Mol Evol (1982) 2.58

Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer (1977) 2.56

Nucleotide sequence of the PR-1 gene of Nicotiana tabacum. FEBS Lett (1987) 2.53

Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex. Virology (1983) 2.53

Towards resolving the interordinal relationships of placental mammals. Syst Biol (1999) 2.53

Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer (2001) 2.46

Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology (1987) 2.46

Plastid genome phylogeny and a model of amino acid substitution for proteins encoded by chloroplast DNA. J Mol Evol (2000) 2.45

Essential role of the small GTPase Rac in disease resistance of rice. Proc Natl Acad Sci U S A (2001) 2.45

Expression cloning of a novel Gal beta (1-3/1-4) GlcNAc alpha 2,3-sialyltransferase using lectin resistance selection. J Biol Chem (1993) 2.40

A woman who trembled, then had chorea. Lancet (1998) 2.40

Evolution of RNA polymerases and branching patterns of the three major groups of Archaebacteria. J Mol Evol (1991) 2.38

Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology (2000) 2.37

A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor. Nature (1993) 2.33

Estimation of right and left ventricular size by ultrasound. A study of the echoes from the interventricular septum. Am J Cardiol (1969) 2.30

On the maximum likelihood method in molecular phylogenetics. J Mol Evol (1991) 2.26

Regulation of the Escherichia coli hfq gene encoding the host factor for phage Q beta. J Bacteriol (1994) 2.26

Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene (1993) 2.25

Nucleotide sequence of the beta-lactamase I gene of Bacillus cereus strains 569/H and 5/B. Nucleic Acids Res (1987) 2.23

Targeted gene disruption demonstrates that P-selectin glycoprotein ligand 1 (PSGL-1) is required for P-selectin-mediated but not E-selectin-mediated neutrophil rolling and migration. J Exp Med (1999) 2.21

Recovery of pathogenic measles virus from cloned cDNA. J Virol (2000) 2.19

Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A (1999) 2.17

Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein. FEBS Lett (1998) 2.15

A second regulatory gene, blaR1, encoding a potential penicillin-binding protein required for induction of beta-lactamase in Bacillus licheniformis. J Bacteriol (1987) 2.15

Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol (1998) 2.14

Six chloroplast genes (ndhA-F) homologous to human mitochondrial genes encoding components of the respiratory chain NADH dehydrogenase are actively expressed: determination of the splice sites in ndhA and ndhB pre-mRNAs. Mol Gen Genet (1987) 2.14

PAR-6 regulates aPKC activity in a novel way and mediates cell-cell contact-induced formation of the epithelial junctional complex. Genes Cells (2001) 2.13

Buoyancy and maximal diving depth in penguins: do they control inhaling air volume? J Exp Biol (2002) 2.12

Relativistic jet activity from the tidal disruption of a star by a massive black hole. Nature (2011) 2.12

Nucleotide sequences of tobacco chloroplast genes for elongator tRNAMet and tRNAVal (UAC): the tRNAVal (UAC) gene contains a long intron. Nucleic Acids Res (1982) 2.11

Establishment of the anti-Klotho monoclonal antibodies and detection of Klotho protein in kidneys. Biochem Biophys Res Commun (2000) 2.11

Retroposon analysis of major cetacean lineages: the monophyly of toothed whales and the paraphyly of river dolphins. Proc Natl Acad Sci U S A (2001) 2.11

Proline-directed and non-proline-directed phosphorylation of PHF-tau. J Biol Chem (1995) 2.09

Detection of beta-lactamase production by gram-negative bacteria. J Antibiot (Tokyo) (1976) 2.06

Overlap and cotranscription of the genes for the beta and epsilon subunits of tobacco chloroplast ATPase. Gene (1983) 2.03

Structure of Marek's disease virus DNA: detailed restriction enzyme map. J Virol (1984) 2.03

Activation of precursors to both glycoporteins of Newcastle disease virus by proteolytic cleavage. Virology (1977) 2.00

Pre-hospital notification reduced the door-to-needle time for iv t-PA in acute ischaemic stroke. Eur J Neurol (2009) 1.97

In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem Biophys Res Commun (2000) 1.97

Topology and subcellular localization of FtsH protein in Escherichia coli. J Bacteriol (1993) 1.93

Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses. FEBS Lett (1999) 1.92

Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoprotein: superiority of furin/PACE to PC2 or PC1/PC3. J Virol (1992) 1.91

Control of mitochondrial redox balance and cellular defense against oxidative damage by mitochondrial NADP+-dependent isocitrate dehydrogenase. J Biol Chem (2001) 1.90

High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet (1999) 1.87

The nucleotide sequences of two tRNAAsn genes from tobacco chloroplasts. Nucleic Acids Res (1981) 1.84

Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin Exp Immunol (2006) 1.84

The preferential codon usages in variable and constant regions of immunoglobulin genes are quite distinct from each other. Nucleic Acids Res (1979) 1.83

Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature (1991) 1.83

Complete sequence and gene organization of the genome of a hyper-thermophilic archaebacterium, Pyrococcus horikoshii OT3 (supplement). DNA Res (1998) 1.81

Ototoxicity of neomycin and its penetration through the round window membrane into the perilymph. Ann Otol Rhinol Laryngol (1986) 1.80

Heterotetrameric complex formation of inositol 1,4,5-trisphosphate receptor subunits. J Biol Chem (1995) 1.79

Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea. Hepatology (2000) 1.78

A rapid and micro method for separation of acidic glycosaminoglycans by two-dimensional electrophoresis. Anal Biochem (1972) 1.76

Molecular assembly of influenza virus: association of the NS2 protein with virion matrix. Virology (1993) 1.76

Molecular cloning and characterization of genes required for ribose transport and utilization in Escherichia coli K-12. J Bacteriol (1984) 1.76

Conflict among individual mitochondrial proteins in resolving the phylogeny of eutherian orders. J Mol Evol (1998) 1.74

Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc Natl Acad Sci U S A (1999) 1.73

Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol (2000) 1.71